Retatrutide 15mg

Retatrutide is an investigational peptide drug being studied for:

• Weight loss
• Blood sugar control
• Appetite suppression
• Metabolic health

It’s a triple agonist, meaning it targets:

• GLP-1
• GIP
• Glucagon receptors

Because of the glucagon activity, it may produce greater fat loss and energy expenditure than older GLP-1 medications in studies.

Research results

Clinical trials have shown very large average weight loss in adults with obesity when combined with diet and exercise. It is still under investigation and not yet broadly approved for general use.